The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation

Health Technol Assess. 2002;6(21):1-110. doi: 10.3310/hta6210.
No abstract available

Publication types

  • Comparative Study
  • Review
  • Systematic Review

MeSH terms

  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / economics
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Cost-Benefit Analysis
  • Data Collection
  • Etanercept
  • Evidence-Based Medicine
  • Humans
  • Immunoglobulin G / economics
  • Immunoglobulin G / therapeutic use*
  • Infliximab
  • Placebo Effect
  • Randomized Controlled Trials as Topic
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Treatment Outcome*
  • United States

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept